Some molecules carried by EVs, such as PD-L1, TGF-β1, FasL, TRAIL, COX2, CD39/CD73, CTLA4, and NKG2D, are involved in tumor evasion and immunosuppression, and therefore hold promise as predictive biomarkers for immunotherapy response [134]. This evidence concerns the gene CD274 and neoplasm.